A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
SMITH & NEPHEW PLC ORD USD0.20 operates in the Medical - Devices industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 6.2B | 6.2B | 5.8B | 5.5B | 5.2B | 5.2B |
| Net Income | 625M | 625M | 412M | 263M | 223M | 524M |
| EPS | $0.72 | $0.72 | $0.47 | $0.30 | $0.26 | $0.60 |
| Free Cash Flow | 1.3B | 1.3B | 987M | 608M | 468M | 877M |
| ROIC | 13.5% | 7.2% | 6.3% | 4.2% | 4.7% | 6.4% |
| Gross Margin | 68.0% | 68.0% | 69.6% | 68.8% | 70.5% | 70.4% |
| Debt/Equity | 0.00 | 0.68 | 0.68 | 0.48 | 0.57 | 0.58 |
| Dividends/Share | $0.38 | $0.38 | $0.37 | $0.38 | $0.37 | $0.38 |
| Operating Income | 794M | 794M | 657M | 425M | 450M | 593M |
| Operating Margin | 12.9% | 12.9% | 11.3% | 7.7% | 8.6% | 11.4% |
| ROE | 11.8% | 11.8% | 7.9% | 5.0% | 4.1% | 9.7% |
| Shares Outstanding | 867M | 867M | 873M | 871M | 875M | 876M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 5.1B | 4.6B | 5.2B | 5.2B | 5.5B | 5.8B | 6.2B | 6.2B |
| Gross Margin | 74.0% | 69.4% | 70.4% | 70.5% | 68.8% | 69.6% | 68.0% | 68.0% |
| R&D | -292M | -307M | -356M | -345M | -339M | -289M | -296M | -296M |
| SG&A | -2.7B | -2.6B | -2.7B | -2.9B | -3.1B | -3.1B | -3.1B | -3.1B |
| EBIT | 815M | 295M | 593M | 450M | 425M | 657M | 794M | 794M |
| Op. Margin | 15.9% | 6.5% | 11.4% | 8.6% | 7.7% | 11.3% | 12.9% | 12.9% |
| Net Income | N/A | 448M | 524M | 223M | 263M | 412M | 625M | 625M |
| Net Margin | N/A | 9.8% | 10.1% | 4.3% | 4.7% | 7.1% | 10.1% | 10.1% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||||
| ROIC | 13.5% | 3.8% | 6.4% | 4.7% | 4.2% | 6.3% | 7.2% | 13.5% |
| ROE | N/A | 8.6% | 9.7% | 4.1% | 5.0% | 7.9% | 11.8% | 11.8% |
| ROA | N/A | 4.1% | 4.8% | 2.1% | 2.6% | 4.1% | 6.0% | 6.0% |
| Cash Flow | ||||||||
| Op. Cash Flow | 1.2B | 935M | 877M | 468M | 608M | 987M | 1.3B | 1.3B |
| Free Cash Flow | 1.2B | 935M | 877M | 468M | 608M | 987M | 1.3B | 1.3B |
| Owner Earnings | 634M | 347M | 269M | -189M | -114M | 302M | 669M | 669M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 502M | 562M | 567M | 617M | 683M | 645M | 573M | 573M |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 502M | 562M | 567M | 617M | 683M | 645M | 573M | 573M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 318M | 328M | 329M | 327M | 327M | 327M | 330M | 330M |
| Dividend Yield | N/A | 2.4% | 2.6% | 3.2% | 3.3% | 3.5% | 3.2% | 3.1% |
| Share Buybacks | 63M | 16M | 0 | 158M | 0 | 0 | 502M | 502M |
| Buyback Yield | 0.0% | 0.1% | 0.0% | 1.7% | 0.0% | 0.0% | 4.7% | 4.7% |
| Stock-Based Comp | 32M | 26M | 41M | 40M | 39M | 40M | 43M | 43M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||||
| Net Debt | N/A | 2.3B | 1.9B | 2.6B | 2.2B | 2.9B | 3.0B | -557M |
| Cash & Equiv. | 257M | 1.8B | 1.3B | 344M | 302M | 619M | 557M | 557M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | 0.77 | 0.58 | 0.57 | 0.48 | 0.68 | 0.68 | 0.00 |
| Interest Coverage | 12.5 | 4.8 | 7.4 | 5.6 | 3.2 | 4.5 | 5.7 | 5.7 |
| Equity | 5.1B | 5.3B | 5.6B | 5.3B | 5.2B | 5.3B | 5.3B | 5.3B |
| Total Assets | N/A | 11.0B | 10.9B | 10.0B | 10.0B | 10.4B | 10.5B | 10.5B |
| Total Liabilities | N/A | 5.7B | 5.4B | 4.7B | 4.8B | 5.1B | 5.2B | 5.2B |
| Intangibles | N/A | N/A | N/A | N/A | N/A | 1.0B | 882M | 882M |
| Retained Earnings | N/A | 5.0B | 5.2B | 5.0B | 4.9B | 5.0B | 5.3B | 5.3B |
| Working Capital | N/A | 3.0B | 2.3B | 2.1B | 1.8B | 2.9B | 2.5B | 2.5B |
| Current Assets | N/A | 4.7B | 4.4B | 3.9B | 4.0B | 4.4B | 4.1B | 4.1B |
| Current Liabilities | N/A | 1.7B | 2.1B | 1.7B | 2.3B | 1.5B | 1.6B | 1.6B |
| Per Share Data | ||||||||
| EPS | 68,400.00 | 0.51 | 0.60 | 0.26 | 0.30 | 0.47 | 0.72 | 0.72 |
| Owner EPS | N/A | 0.40 | 0.31 | -0.22 | -0.13 | 0.35 | 0.77 | 0.77 |
| Book Value | N/A | 6.04 | 6.35 | 6.01 | 5.99 | 6.03 | 6.10 | 6.10 |
| Cash Flow/Share | N/A | 1.07 | 1.00 | 0.54 | 0.70 | 1.13 | 1.48 | 1.38 |
| Dividends/Share | N/A | 0.38 | 0.38 | 0.37 | 0.38 | 0.37 | 0.38 | 0.38 |
| Shares Out. | N/A | 873.3M | 876.3M | 874.5M | 870.9M | 872.9M | 866.9M | 866.9M |
| Valuation | ||||||||
| P/E Ratio | 0.0 | 30.0 | 20.8 | 42.4 | 35.8 | 20.9 | 17.0 | 17.3 |
| P/FCF | N/A | 14.3 | 12.4 | 20.2 | 15.4 | 8.7 | 8.2 | 8.4 |
| EV/EBIT | N/A | 53.2 | 21.6 | 26.9 | 27.3 | 17.5 | 17.1 | 12.9 |
| Price/Book | N/A | 2.5 | 2.0 | 1.8 | 1.8 | 1.6 | 2.0 | 2.0 |
| Price/Sales | N/A | 2.9 | 2.1 | 1.8 | 1.7 | 1.5 | 1.7 | 1.7 |
| FCF Yield | N/A | 7.0% | 8.1% | 5.0% | 6.5% | 11.5% | 12.1% | 11.9% |
| Market Cap | 0 | 13.4B | 10.9B | 9.4B | 9.4B | 8.6B | 10.6B | 10.8B |
| Avg. Price | 16.66 | 15.92 | 14.26 | 11.57 | 11.29 | 10.59 | 11.76 | 12.42 |
| Year-End Price | 18.37 | 15.35 | 12.40 | 10.80 | 10.79 | 9.83 | 12.21 | 12.42 |
SMITH & NEPHEW PLC ORD USD0.20 passes 5 of 9 quality checks, suggesting mixed fundamentals.
SMITH & NEPHEW PLC ORD USD0.20 trades at 17.3x trailing earnings, compared to its 15-year median P/E of 20.9x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 8.4x vs a median of 13.4x. The company's 5-year average ROIC is 5.8% with a gross margin of 69.5%. Total shareholder yield (dividends + buybacks) is 7.7%. At current prices, the estimated annualized return to fair value is -1.9%.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) has a current P/E ratio of 17.3, compared to its historical median P/E of 20.9. The stock is currently considered Fair based on its historical valuation range.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) has a 5-year average return on invested capital (ROIC) of 5.8%. This is below average and may indicate limited pricing power.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) has a market capitalization of $10.8B. It is classified as a large-cap stock.
Yes, SMITH & NEPHEW PLC ORD USD0.20 (SN-L) pays a dividend with a trailing twelve-month yield of 3.07%. The company also returns capital through share buybacks, with a buyback yield of 4.66%.
Based on historical P/E analysis, SMITH & NEPHEW PLC ORD USD0.20 (SN-L) appears fair. The current P/E of 17.3 is 17% below its historical median of 20.9. The estimated fair value CAGR (P/E method) is -3.4%.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) operates in the Medical - Devices industry, within the Healthcare sector.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) reported annual revenue of $6.2 billion in its most recent fiscal year, based on SEC EDGAR filings.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) has a net profit margin of 10.1%. This is a healthy margin.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) generated $1.3 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) has a debt-to-equity ratio of 0.68. This indicates moderate leverage.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) reported earnings per share (EPS) of $0.72 in its most recent fiscal year.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) has a return on equity (ROE) of 11.8%. This indicates moderate shareholder returns.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) has a 5-year average gross margin of 69.5%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 7 years of financial data for SMITH & NEPHEW PLC ORD USD0.20 (SN-L), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
SMITH & NEPHEW PLC ORD USD0.20 (SN-L) has a book value per share of $6.10, based on its most recent annual SEC filing.
No recent press releases.